NCT03503344 2026-01-21
PILLAR
University of California, San Francisco
Phase 2 Completed
Clinical Trials
3 trialsNCT03406858 2023-05-03
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT02215161 2018-06-26
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
University of California, San Francisco
Phase 2 Terminated